Thornal Kevin R's Form 4 filing
Hologic IncHOLX · filed Nov 17, 2022
- Accession no.
- 0001127602-22-025948
- Filed
- Nov 17, 2022
- Trade date
- Nov 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.44M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thornal Kevin RCIK 0001783992 | Officer (Group Pres, Global Diagnostics) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | SSaleDisposed | −6,628 | $75.37F1 | −$499,552.36 | 62,368 | Direct | |
| Nov 15, 2022 | Common Stock | MOption exerciseAcquired | +12,490 | $40.85 | +$510,216.5 | 74,858 | Direct | |
| Nov 15, 2022 | Common Stock | SSaleDisposed | −12,490 | $75.30F2 | −$940,497 | 62,368 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Common Stock | MOption exerciseDisposed | −12,490 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.35 to $75.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.26 to $75.372 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
Referenced by the price of 1 transaction in Table I.